I agree, most folks are unaware of the ground-breaking developments that K is producing. BUT, CTIX has zero level of sponsorship in the investment community and it is still a pinkie.
We must have some third party sponsorship and/or a deal in order to have the share price reflect a decent representation of the value.

I think DF is planning to do the ovarian P2 trial and will most likely sponsor it. The ASCO presentation was (IMO) notice to the medical community.

Go CTIX!!